Published ahead of print on July 11, 2003, doi:10.1164/rccm.200209-1070OC
Am. J. Respir. Crit. Care Med., Volume 168, Number 6, September 2003, 706-713
A more recent version of this article appeared on September 15, 2003
Submitted on September 24, 2002
Accepted on July 3, 2003
HUMAN DIAPHRAGM REMODELING ASSOCIATED WITH COPD: CLINICAL IMPLICATIONS
Sanford Levine1*, Taitan Nguyen1, Larry R Kaiser2, Neal A Rubinstein2, Greg Maislin2, Christopher Gregory3, Lawrence C Rome4, Gary A Dudley5, Gary C Sieck3, and Joseph B Shrager1
1 Surgical and Research Services, VA Medical Center, Philadelphia, PA, USA; Surgery, Medicine, Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA,
2 Surgery, Medicine, Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA,
3 Physiology and Biophysics, and Anesthesiology, Mayo Medical School, Clinic, and Foundation, Rochester, MN, USA,
4 Biology, University of Pennsylvania School of Arts and Sciences, Philadelphia, PA, USA,
5 Exercise Science, University of Georgia, Athens, GA, USA
* To whom correspondence should be addressed. E-mail: sdlevine{at}mail.med.upenn.edu.
Diaphragm remodeling associated with COPD consists of a fast-to-slow fiber-type transformation as well as adaptations within each fiber type. To try to explain disparate findings in the literature regarding the relationship between fiber-type proportions and FEV1.0, we obtained costal diaphragm biopsies on 40 subjects whose FEV1.0 ranged from 118-to-16% predicted normal. First, we noted that our exponential regression model indicated that changes in FEV1.0 can account for 72% of the variation in the proportion of type I fibers. Second, to assess the impact of COPD on diaphragm force generation, we measured maximum specific force generated by single permeabilized fibers prepared from the diaphragms of two patients with normal pulmonary function tests and two patients with severe COPD. We noted that fibers prepared from the diaphragms of severe COPD patients generated a lower specific force than control fibers (p<0.001) and type I fibers generated a lower specific force than type II fibers (p<0.001). Our finding of an exponential relationship between the proportion of type I fibers and FEV1.0 accounts for discrepancies in the literature. Moreover, our single fiber results suggest that COPD-associated diaphragm remodeling decreases diaphragmatic force generation by adaptations within each fiber type as well as by fiber-type transformations.
Key words: COPD, fiber type transformations, within fiber type adaptations, single fiber physiology, specific force
This article has been cited by other articles:

|
 |

|
 |
 
A. K. Stubbings, A. J. Moore, M. Dusmet, P. Goldstraw, T. G. West, M. I. Polkey, and M. A. Ferenczi
Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease
J. Physiol.,
May 15, 2008;
586(10):
2637 - 2650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Levine, T. Nguyen, N. Taylor, M. E. Friscia, M. T. Budak, P. Rothenberg, J. Zhu, R. Sachdeva, S. Sonnad, L. R. Kaiser, et al.
Rapid Disuse Atrophy of Diaphragm Fibers in Mechanically Ventilated Humans
N. Engl. J. Med.,
March 27, 2008;
358(13):
1327 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Casadevall, C. Coronell, A. L. Ramirez-Sarmiento, J. Martinez-Llorens, E. Barreiro, M. Orozco-Levi, J. Gea, and on behalf of the ENIGMA in COPD group
Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients
Eur. Respir. J.,
October 1, 2007;
30(4):
701 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. C. Ottenheijm, G. J. Jenniskens, M. C. P. Geraedts, T. Hafmans, L. M. A. Heunks, T. H. van Kuppevelt, and P. N. R. Dekhuijzen
Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate?
Eur. Respir. J.,
July 1, 2007;
30(1):
80 - 89.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. C. Ottenheijm, L. M. A. Heunks, and P. N. R. Dekhuijzen
Diaphragm Muscle Fiber Dysfunction in Chronic Obstructive Pulmonary Disease: Toward a Pathophysiological Concept
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1233 - 1240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Levine, T. Nguyen, M. Friscia, J. Zhu, W. Szeto, J. C. Kucharczuk, B. A. Tikunov, N. A. Rubinstein, L. R. Kaiser, and J. B. Shrager
Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease
J Appl Physiol,
November 1, 2006;
101(5):
1297 - 1302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. C. Ottenheijm, L. M. A. Heunks, Y.-P. Li, B. Jin, R. Minnaard, H. W. H. van Hees, and P. N. R. Dekhuijzen
Activation of the Ubiquitin-Proteasome Pathway in the Diaphragm in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
November 1, 2006;
174(9):
997 - 1002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. C. Ottenheijm, L. M. A. Heunks, T. Hafmans, P. F. M. van der Ven, C. Benoist, H. Zhou, S. Labeit, H. L. Granzier, and P. N. R. Dekhuijzen
Titin and Diaphragm Dysfunction in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
March 1, 2006;
173(5):
527 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Gorman, D. K. McKenzie, J. E. Butler, J. F. Tolman, and S. C. Gandevia
Diaphragm Length and Neural Drive after Lung Volume Reduction Surgery
Am. J. Respir. Crit. Care Med.,
November 15, 2005;
172(10):
1259 - 1266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers
Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease
Chest,
November 1, 2005;
128(5):
3618 - 3624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. C. Ottenheijm, L. M. A. Heunks, G. C. Sieck, W.-Z. Zhan, S. M. Jansen, H. Degens, T. de Boo, and P. N. R. Dekhuijzen
Diaphragm Dysfunction in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 15, 2005;
172(2):
200 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2005;
172(1):
19 - 38.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nguyen, N. A. Rubinstein, C. Vijayasarathy, L. C. Rome, L. R. Kaiser, J. B. Shrager, and S. Levine
Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm
J Appl Physiol,
June 1, 2005;
98(6):
2004 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Barreiro, B. de la Puente, J. Minguella, J. M. Corominas, S. Serrano, S. N. A. Hussain, and J. Gea
Oxidative Stress and Respiratory Muscle Dysfunction in Severe Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
May 15, 2005;
171(10):
1116 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Laghi, W. E. Langbein, A. Antonescu-Turcu, A. Jubran, C. Bammert, and M. J. Tobin
Respiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
598 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Sleep-Disordered Breathing, Control of Breathing, Respiratory Muscles, Pulmonary Function Testing in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
254 - 264.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
301 - 313.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|